LIGAND PHARMACEUTICALS INCORPORATED Research and Development in Process
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Research and Development in Process of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2016-11-14
- LIGAND PHARMACEUTICALS INCORPORATED research and development in process for the quarter ending 2011-12-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED research and development in process for the quarter ending 2011-09-30 was $2.28M.
- LIGAND PHARMACEUTICALS INCORPORATED research and development in process for fiscal 2015 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED research and development in process for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- LIGAND PHARMACEUTICALS INCORPORATED research and development in process for fiscal 2013 was $480.00K.
- LIGAND PHARMACEUTICALS INCORPORATED research and development in process for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month | Research and Development in Process 12 month as first filed |
|---|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-11-14 | ||||
| 2014-12-31 | $0.00 10-K · filed 2016-11-14 | $480.00K 10-K · filed 2014-12-01 | |||
| 2013-12-31 | $480.00K 10-K · filed 2016-11-14 | ||||
| 2012-12-31 | $0.00 10-K · filed 2015-02-23 | ||||
| 2011-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | $2.28M derived: sum of 2 quarters · filed 2014-12-12 | $2.28M 10-K/A · filed 2014-12-12 | ||
| 2011-09-30 | $2.28M 10-Q · filed 2012-11-14 | $2.28M 10-Q · filed 2012-11-14 | |||
| 2010-12-31 | $2.75M 10-K · filed 2013-03-14 | ||||
| 2009-12-31 | $442.00K 10-K/A · filed 2012-11-14 |